Is DERM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DERM. It does not provide personalized investment advice.

DERM (Journey Medical Corporation Common Stock) Stock Analysis - Financials

Journey Medical Corporation Common Stock (DERM) is a publicly traded Healthcare sector company. As of August 5, 2026, DERM trades at $6.43 with a market cap of $178.15M and a P/E ratio of -17.47. DERM moved +0.00% today. Year to date, DERM is -16.99%; over the trailing twelve months it is -10.36%. Its 52-week range spans $3.54 to $9.56. Analyst consensus is strong buy with an average price target of $14.00. Rallies surfaces DERM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are DERM's key financials?

DERM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DERM recently traded at $6.43. Market cap is $178.15M. P/E ratio is -17.47. Revenue is $64.68M.

DERM Key Metrics

Key financial metrics for DERM
Metric	Value
Price	$6.43
Market Cap	$178.15M
P/E Ratio	-17.47
EPS	$-0.37
Dividend Yield	0.00%
52-Week High	$9.56
52-Week Low	$3.54
Volume	30.78K
Avg Volume	0
Revenue (TTM)	$64.68M
Net Income	$-9.59M
Gross Margin	65.44%

DERM Analyst Consensus

3 analysts cover DERM: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.00.

Common questions about DERM

What are DERM's key financials?: DERM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DERM recently traded at $6.43. Market cap is $178.15M. P/E ratio is -17.47. Revenue is $64.68M.
Is DERM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DERM. It does not provide personalized investment advice.